Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-021060

Director sold 6,800 shares at $81.97 ($557,396)

  • Director acquired 6,800 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Foster-Cheek Kaye I Director 2018-03-19 Option exercise +6,800 $47.33 $321,844 9,000 D: show line 1 in the form
Foster-Cheek Kaye I Director 2018-03-19 Sale −6,800 $81.97 $557,396 2,200 D: show line 2 in the form
Open-market sales · 6,800 sh · avg $81.97 · $557,396

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Foster-Cheek Kaye I Director 2018-03-19 Option exercise · Stock option (right to buy) −6,800 0 D: show line 3 in the form
Loading xslF345X03/doc4.xml…